Does Dr. FRANCISCO ACEBO have financial conflicts of interest?

Dr. FRANCISCO ACEBO (M.D.) has received a total of $3,036 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $3,036 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. FRANCISCO ACEBO?

According to CMS Open Payments data, Dr. FRANCISCO ACEBO received funding from NOVO NORDISK ($638), ASTRAZENECA PHARMACEUTICALS ($430), and SANOFI-AVENTIS U.S ($344).

Does Dr. FRANCISCO ACEBO receive research grants or speaking fees?

Dr. FRANCISCO ACEBO has received $3,036 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. FRANCISCO ACEBO

M.D.Real-Time Hydrated

Specialty: Family Medicine, Adult Medicine

Practice Location: CORPUS CHRISTI, TX 78404

NPI Number: 1912980962

LIFETIME INDUSTRY VALUE

$3,036

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ACEBO is a verified Family Medicine, Adult Medicine practitioner based in CORPUS CHRISTI, TX.

Between 2021 and 2024, Dr. ACEBO had an overall industry promotional and research financial footprint of $3,036 as recorded in the federal CMS Open Payments database.

$3,036 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ACEBO's primary funding source is NOVO NORDISK, which accounts for $638 (representing 21% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

NOVO NORDISK

Rank 1

$638

21%

ASTRAZENECA PHARMACEUTICALS

Rank 2

$430

14.2%

SANOFI-AVENTIS U.S

Rank 3

$344

11.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.